Novel Corticosteroid Approved for Rare Disease

(MedPage Today) -- Vamorolone (Agamree), a novel corticosteroid treatment, won FDA approval to treat Duchenne muscular dystrophy (DMD) in patients ages 2 years and older, Catalyst Pharmaceuticals announced Thursday. The dissociative steroidal...
Source: MedPage Today Public Health - Category: American Health Source Type: news